Analyst Ratings for United Therapeutics Corp. (UTHR)

Overall Rating: NEUTRAL Rating Trend:

Avg. $ Target: $49.50 (-28.4%)

Date	Firm	Type	Rating (Past)	PT (Past)	Start $	End $	% Chg.	Details
5/15/2013	Standpoint Research	Downgrade	Hold (Buy)	N/A (N/A)	68.25	69.17	1.35%	Details
4/26/2013	Ladenburg Thalmann	Downgrade	Neutral (Buy)	N/A (N/A)	61.67	69.17	12.16%	Details
2/26/2013	Brean Capital	Downgrade	Hold (Buy)	N/A (N/A)	57.66	69.17	19.96%	Details
1/23/2013	Guggenheim	New Coverage	Neutral (N/A)	58.00 (N/A)	53.45	69.17	29.41%	Details
12/13/2012	Goldman Sachs	Downgrade	Sell (Neutral)	50.00 (50.00)	52.16	69.17	32.61%	Details
10/24/2012	JPMorgan	Downgrade	Underweight (Neutral)	40.00 (50.00)	46.68	69.17	48.18%	Details
10/24/2012	BMO Capital	Downgrade	Market Perform (Outperform)	50.00 (63.00)	46.68	69.17	48.18%	Details
4/27/2012	Canaccord Genuity » Updated 7/27/2012	Downgrade	Hold (N/A)	44.00 (N/A)	44.54	69.17	55.3%	Details
4/12/2012	Leerink Swann	Downgrade	Market Perform (N/A)	48.00 (N/A)	43.73	69.17	58.18%	Details
8/25/2011	Maxim Group	Downgrade	Hold (N/A)	N/A (N/A)	39.91	69.17	73.31%	Details
8/25/2011	Citi	Downgrade	Neutral (N/A)	44.00 (N/A)	39.91	69.17	73.31%	Details
8/24/2011	Deutsche Bank » Updated 2/27/2013	Downgrade	Hold (N/A)	56.00 (52.00)	39.15	69.17	76.68%	Details
6/13/2011	RBC Capital	Downgrade	Sector Perform (N/A)	N/A (N/A)	57.96	69.17	19.34%	Details
6/7/2011	Citadel Securities » Updated 7/28/2011	Downgrade	Neutral (N/A)	60.00 (N/A)	59.00	69.17	17.24%	Details
4/29/2011	Auriga » Updated 2/15/2012	New Coverage	Buy (N/A)	45.00 (N/A)	67.66	39.91	-41.01%	Details